Annual Short Term Debt
$5.44 M
+$207.00 K+3.96%
31 December 2023
Summary:
Pharming Group NV annual short term debt is currently $5.44 million, with the most recent change of +$207.00 thousand (+3.96%) on 31 December 2023. During the last 3 years, it has risen by +$1.44 million (+35.93%). PHAR annual short term debt is now -89.79% below its all-time high of $53.31 million, reached on 31 December 2019.PHAR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$7.20 M
+$231.00 K+3.31%
30 September 2024
Summary:
Pharming Group NV quarterly short term debt is currently $7.20 million, with the most recent change of +$231.00 thousand (+3.31%) on 30 September 2024. Over the past year, it has increased by +$1.68 million (+30.50%). PHAR quarterly short term debt is now -94.81% below its all-time high of $138.77 million, reached on 31 March 2024.PHAR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | +30.5% |
| 3 y3 years | +35.9% | +59.4% |
| 5 y5 years | -86.6% | -82.0% |
PHAR Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.9% | -94.8% | +82.3% |
| 5 y | 5 years | -89.8% | +35.9% | -94.8% | +313.9% |
| alltime | all time | -89.8% | +9279.3% | -94.8% | >+9999.0% |
Pharming Group NV Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.20 M(+3.3%) |
| June 2024 | - | $6.97 M(-95.0%) |
| Mar 2024 | - | $138.77 M(+2450.9%) |
| Dec 2023 | $5.44 M(+4.0%) | $5.44 M(-1.4%) |
| Sept 2023 | - | $5.52 M(-2.4%) |
| June 2023 | - | $5.65 M(-1.7%) |
| Mar 2023 | - | $5.75 M(+9.9%) |
| Dec 2022 | $5.23 M(+21.8%) | $5.23 M(+32.5%) |
| Sept 2022 | - | $3.95 M(-4.1%) |
| June 2022 | - | $4.12 M(-4.7%) |
| Mar 2022 | - | $4.32 M(+0.6%) |
| Dec 2021 | $4.30 M(+7.4%) | $4.30 M(-4.8%) |
| Sept 2021 | - | $4.52 M(-2.3%) |
| June 2021 | - | $4.62 M(-6.8%) |
| Mar 2021 | - | $4.96 M(+23.9%) |
| Dec 2020 | $4.00 M(-92.5%) | $4.00 M(+95.5%) |
| Sept 2020 | - | $2.05 M(+17.7%) |
| June 2020 | - | $1.74 M(-4.0%) |
| Mar 2020 | - | $1.81 M(-96.6%) |
| Dec 2019 | $53.31 M(+31.3%) | $53.31 M(+33.4%) |
| Sept 2019 | - | $39.97 M(-1.3%) |
| June 2019 | - | $40.49 M(+2.3%) |
| Mar 2019 | - | $39.56 M(-2.6%) |
| Dec 2018 | $40.61 M(+49.4%) | $40.61 M(-3.4%) |
| Sept 2018 | - | $42.05 M(+2.6%) |
| June 2018 | - | $40.97 M(+17.7%) |
| Mar 2018 | - | $34.80 M(+28.0%) |
| Dec 2017 | $27.19 M | $27.19 M(+34.8%) |
| Sept 2017 | - | $20.17 M(+56.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $12.92 M(-61.5%) |
| Mar 2017 | - | $33.58 M(+21.0%) |
| Dec 2016 | $27.76 M(+667.2%) | $27.76 M(+319.8%) |
| Sept 2016 | - | $6.61 M(+6.8%) |
| June 2016 | - | $6.19 M(+27.2%) |
| Mar 2016 | - | $4.87 M(+34.6%) |
| Dec 2015 | $3.62 M(+375.4%) | $3.62 M(+59.5%) |
| Sept 2015 | - | $2.27 M(+858.8%) |
| June 2015 | - | $236.70 K(-28.1%) |
| Mar 2015 | - | $329.20 K(-56.8%) |
| Dec 2014 | $761.20 K(-28.0%) | $761.20 K(+29.9%) |
| Sept 2014 | - | $586.20 K(-9.0%) |
| June 2014 | - | $643.90 K(-3.9%) |
| Mar 2014 | - | $669.80 K(-36.7%) |
| Dec 2013 | $1.06 M(-10.6%) | $1.06 M(-73.3%) |
| Sept 2013 | - | $3.96 M(-57.5%) |
| June 2013 | - | $9.33 M(-30.7%) |
| Mar 2013 | - | $13.46 M(+1037.5%) |
| Dec 2012 | $1.18 M(-25.0%) | $1.18 M(-1.9%) |
| Sept 2012 | - | $1.21 M(-78.2%) |
| Mar 2012 | - | $5.54 M(+250.7%) |
| Dec 2011 | $1.58 M(+2539.8%) | $1.58 M(+2539.8%) |
| Dec 2010 | $59.80 K(-99.8%) | $59.80 K(-99.6%) |
| Sept 2010 | - | $15.15 M(-64.0%) |
| June 2010 | - | $42.09 M(-13.5%) |
| Mar 2010 | - | $48.69 M(+46.3%) |
| Dec 2009 | $33.27 M(+27.0%) | $33.27 M |
| Dec 2008 | $26.21 M(+1157.5%) | - |
| Dec 2006 | $2.08 M(+3493.1%) | - |
| Dec 2005 | $58.00 K | - |
FAQ
- What is Pharming Group NV annual short term debt?
- What is the all time high annual short term debt for Pharming Group NV?
- What is Pharming Group NV annual short term debt year-on-year change?
- What is Pharming Group NV quarterly short term debt?
- What is the all time high quarterly short term debt for Pharming Group NV?
- What is Pharming Group NV quarterly short term debt year-on-year change?
What is Pharming Group NV annual short term debt?
The current annual short term debt of PHAR is $5.44 M
What is the all time high annual short term debt for Pharming Group NV?
Pharming Group NV all-time high annual short term debt is $53.31 M
What is Pharming Group NV annual short term debt year-on-year change?
Over the past year, PHAR annual short term debt has changed by +$207.00 K (+3.96%)
What is Pharming Group NV quarterly short term debt?
The current quarterly short term debt of PHAR is $7.20 M
What is the all time high quarterly short term debt for Pharming Group NV?
Pharming Group NV all-time high quarterly short term debt is $138.77 M
What is Pharming Group NV quarterly short term debt year-on-year change?
Over the past year, PHAR quarterly short term debt has changed by +$1.68 M (+30.50%)